Bladder Cancer
The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes
December 12, 2016
Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples
December 12, 2016
Associations between interventions for urolithiasis and urinary tract cancer among patients in Taiwan: The effect of early intervention
December 12, 2016
Urothelium-adherent, ion-triggered liposome-in-gel system as a platform for intravesical drug delivery
December 9, 2016
Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression
December 9, 2016
Atezolizumab: a PD-L1 blocking antibody for bladder cancer
December 7, 2016
Final results of the phase III URO-BCG 4 multicenter study: efficacy and tolerance of one-third dose BCG maintenance in nonmuscle invasive bladder cancer
December 7, 2016
Systematic review of perioperative outcomes and complications after open, laparoscopic and robot-assisted radical cystectomy
December 6, 2016
Impact of neoadjuvant chemotherapy on complications of minimally invasive radical cystectomy
December 6, 2016
Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization
December 5, 2016
Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma
December 2, 2016
Squamous Cell Carcinoma of the Bladder: A SEER Database Analysis
December 2, 2016